Mineralys Therapeutics (MLYS) Earnings Date, Estimates & Call Transcripts $15.48 +1.01 (+6.98%) As of 03:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Mineralys Therapeutics Earnings Summary Mineralys Therapeutics issued Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.66, which beat the consensus estimate of -$0.78 by $0.12. With a trailing EPS of -$3.56, Mineralys Therapeutics' earnings are expected to decrease next year, from ($4.23) to ($4.48) per share. Latest Q2 Earnings DateAug. 12EstimatedConsensus EPS (Aug. 12) -$0.78 Actual EPS (Aug. 12) -$0.66 Beat By $0.12 Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)SEC FilingPowered by Get Mineralys Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mineralys Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMLYS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Mineralys Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.90-$0.90-$0.90Q2 20252-$0.85-$0.81-$0.83Q3 20252-$0.74-$0.69-$0.72Q4 20252-$0.82-$0.71-$0.77 Mineralys Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025-$0.78-$0.66+$0.12-$0.66--5/12/2025Q1 2025-$1.02-$0.79+$0.23-$0.79--2/12/2025Q4 2024-$1.00-$0.98+$0.02-$0.98--11/11/2024Q3 2024-$0.83-$1.13 -$0.30-$1.13--8/13/2024Q2 2024-$0.73-$0.83 -$0.10-$0.83--5/9/2024Q1 2024-$0.68-$0.70 -$0.02-$0.70--3/21/2024Q4 2023-$0.85-$0.61+$0.24-$0.61--11/7/2023Q3 2023-$0.72-$0.57+$0.15-$0.57-- Mineralys Therapeutics Earnings - Frequently Asked Questions When did Mineralys Therapeutics announce their last quarterly earnings? Mineralys Therapeutics (NASDAQ:MLYS) last announced its quarterly earning data on Tuesday, August 12, 2025. Learn more on MLYS's earnings history. Did Mineralys Therapeutics beat their earnings estimates last quarter? In the previous quarter, Mineralys Therapeutics (NASDAQ:MLYS) reported ($0.66) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.78) by $0.12. Learn more on analysts' earnings estimate vs. MLYS's actual earnings. How can I listen to Mineralys Therapeutics' earnings conference call? The conference call for Mineralys Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Mineralys Therapeutics' conference call transcript? The conference call transcript for Mineralys Therapeutics' latest earnings report can be read online. Read Transcript How can I view Mineralys Therapeutics' earnings report? Mineralys Therapeutics' earnings report can be found in their filing with the SEC. View SEC filing How much profit does Mineralys Therapeutics generate each year? Mineralys Therapeutics (NASDAQ:MLYS) has a recorded net income of -$177.81 million. MLYS has generated -$3.56 earnings per share over the last four quarters. What is Mineralys Therapeutics' EPS forecast for next year? Mineralys Therapeutics' earnings are expected to decrease from ($4.23) per share to ($4.48) per share in the next year. More Earnings Resources from MarketBeat Related Companies LNTH Earnings Date APLS Earnings Date MLTX Earnings Date PTGX Earnings Date MIRM Earnings Date MTSR Earnings Date BHC Earnings Date KYMR Earnings Date SRRK Earnings Date AMRX Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles DLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals? This page (NASDAQ:MLYS) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mineralys Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access